Bausch Health Companies price to free cash flow BHC

Market value divided by free cash flow over the last twelve months, since 2011.

Today, Oct 23, 2026: 1.7×
10-year median: 4.1×
Against its 10-year history: 4th; percentile: 0 is its lowest day, 100 its highest
10-year range: 1.3× to 17.4×
Peer median: 9.6×

Bausch Health Companies' price to free cash flow is 1.7× as of Oct 23, 2026.

That is below its ten-year median of 4.1×, lower than on 96% of days in the last ten years.

Over that time it ranged from 1.3× in Apr 2025 to 17.4× in Feb 2021.

The median for 10 large drugmakers of a similar size is 9.6×.

Price to free cash flow over time

median 4.1×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	1.7×	1.5×	2.5×
2025	2.4×	1.3×	2.8×
2024	2.7×	2.1×	4.7×
2023	3.1×	2.7×	3.1×
2022	5.8×	2.5×	7.6×
2021	6.5×	5.6×	17.4×
2020	11.3×	3.8×	11.3×
2019	7.9×	4.6×	8.2×
2018	4.1×	2.4×	5.9×
2017	3.5×	1.6×	3.7×
2016	2.7×	2.6×	15.0×
2015	15.8×	11.7×	43.1×
2014	32.0×	28.5×	64.9×
2013	50.4×	27.1×	55.0×
2012	26.3×	19.3×	36.2×
2011	33.2×	27.8×	62.4×

Against its peers

Companies in Drug Manufacturers - General nearest Bausch Health Companies' size, closest first, today.

Company	Price to free cash flow
BHCBausch Health Companies	1.7×
PBHPrestige Consumer Healthcare	9.6×
HRMYHarmony Biosciences	n/m
NRIXNurix Therapeutics	7.5×
ANIPANI Pharmaceuticals	9.6×
OGNOrganon	6.4×
PAHCPhibro Animal Health	160×
LQDALiquidia	25.3×
ARQTArcutis Biotherapeutics	100×
ANABAnaptysbio	n/m
PCRXPacira BioSciences	8.1×
Peer median	9.6×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Bausch Health Companies

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.